# Study of Oligo-Fucoidan in Advanced Hepatocellular Carcinoma (HCC)

> **NCT04066660** · NA · TERMINATED · sponsor: **Hi-Q Marine Biotech International, Ltd.** · enrollment: 87 (actual)

## Conditions studied

- Advanced Hepatocellular Carcinoma

## Interventions

- **DIETARY_SUPPLEMENT:** Oligo Fucoidan
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04066660
- **Lead sponsor:** Hi-Q Marine Biotech International, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-10-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-07-31
- **Target enrollment:** 87 (ACTUAL)
- **Why stopped:** After interim analysis, we planned to recruit 100 participants. However, due to COVID-19 challenges, statistician advised each group needs at least 30 samples (Gay, 1992). The sponsor and team decided to terminate the trial early for valid data.
- **Last updated:** 2025-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04066660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04066660, "Study of Oligo-Fucoidan in Advanced Hepatocellular Carcinoma (HCC)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04066660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*